Abstract
Brain metastases occur in up to 40% of patients with cancer. Their management has been revolutionized in the last decade by three developments: improved imaging and detection of metastases, better treatment of systemic disease with the result that metastases occur more often; and improved surgical techniques including image-guided surgery to treat metastatic lesions. Class 1 data suggest that surgery is a better treatment for metastases than whole brain radiation. Other data suggest that metastases even in eloquent cortex can be removed safely. The complication rate is low and the recurrence rate is less than 10%.
In general, indications for surgery include a mass with an unknown primary; a symptomatic mass including one in eloquent areas; a mass with considerable edema requiring high dose steroids; a mass greater than 3 cm; or patient preference when radiosurgery may also be an option. The question of radiosurgery or whole brain radiation as adjunct to surgical removal requires further evaluation.
Similar content being viewed by others
References
Soffietti R, Ruda R, Mutani R: Management of brain metastases. J Neurol 249(10): 1357–1369, 2002
Weinberg JS, Lang FF, Sawaya R: Surgical management of brain metastases. Curr Oncol Rep (6): 476–483, 2001
Schiff D: Single brain metastasis. Curr Treat Options Neurol 3(1): 89–99, 2001
DiStefano A, Yong Yap Y, Hortobagyi GN, Blumenschein GR: The natural history of breast cancer patients with brain metastases. Cancer 44: 1913–1918, 1979
Borgelt B, Gelber R, Kramer S et al: The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6: 1–9, 1980
Kamby C, Soerensen PS: Characteristics of patients with short and long survivals after detection of intracranial metastases from breast cancer. J Neurooncol 6: 37–45, 1986
Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43(4): 795–803, 1999
Saitoh Y, Fujisawa T, Shiba M, Yoshida S, Sekine Y, Baba M, Iizasa T, Kubota M: Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. Lung Cancer 24(2): 99–106, 1999
Wronski M, Arbit E, McCormick B, Wronski M: Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 80(9): 1746–1754, 1997
DeAngelis L, Rogers L, Foley KM: Leptomeningeal metastasis. In: Harris JR (ed) Diseases of the Breast. Lippincott Williams & Wilkins, Philadelphia, 2000, pp. 867–874
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8): 494–500, 1990
Agboola O, Benoit B, Cross P, Da Silva V, Esche B, Lesiuk H, Gonsalves C: Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 42(1): 155–159, 1998
Iwadate Y, Namba H, Yamaura A: Significance of surgical resection for the treatment of multiple brain metastases. Anticancer Res 20(1B): 573–577, 2000
Bindal RK, Sawaya R, Leavens ME, Lee JJ: Surgical treatment of mutliple brain metastases. J Neurosurg 79(2): 210–216, 1993
Korinth MC, Delonge C, Hutter BO, Gilsbach JM: Prognostic factors for patients with microsurgically resected brain metastases. Onkologie 25(5): 420–425, 2002
Tan TC, McL Black P: Image-guided craniotomy for cerebral metastases: techniques and outcomes. Neurosurgery 53(1): 82–89; discussion 89–90, 2003
Schackert G, Steinmetz A, Meier U, Sobottka SB: Surgical management of single and multiple brain metastases: results of a retrospective study. Onkologie 24(3): 246–255, 2001
Auchter RM, Lamond JP, Alesander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP: A multiinstitutional outcome and prognostic factor analysis of radio-surgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35(1): 27–35, 1996
O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR: A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 55(5): 1169–1176, 2003
Shinoura N, Yamada R, Okamoto K, Nakamura O, Shitara N: Local recurrence of metastatic brain tumor after stereotactic radiosurgery or surgery plus radiation. J Neurooncol 60(1): 71–77, 2002
Schoggl A, Kitz K, Reddy M, Wolfsberger S, Schneider B, Dieckmann K, Ungersbock K: Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 142(6): 621–626, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Black, P.M., Johnson, M.D. Surgical Resection for Patients with Solid Brain Metastases: Current Status. J Neurooncol 69, 119–124 (2004). https://doi.org/10.1023/B:NEON.0000041875.09048.e7
Issue Date:
DOI: https://doi.org/10.1023/B:NEON.0000041875.09048.e7